Abbott Laboratories
Change company Symbol lookup
Select an option...
ABT Abbott Laboratories
NVS Novartis AG
UNM Unum Group
LLY Eli Lilly and Co
BDC Belden Inc
TTM Tata Motors Ltd
HOG Harley-Davidson Inc
SKY Skyline Champion Corp

Health Care : Health Care Equipment & Supplies | Large Cap Blend
Company profile

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products.

Day's Change
-2.79 (-2.56%)
B/A Size
Day's High
Day's Low
(Heavy Day)

Today's volume of 2,293,531 shares is on pace to be much greater than ABT's 10-day average volume of 4,623,598 shares.




6 providers
Today's News, October 28, 2020
JPMorgan Chase Elects Phebe N. Novakovic to its Board of Directors

JPMorgan Chase (NYSE: JPM) announced today that Phebe N. Novakovic, 62, has been elected as a director of the company, effective December 7, 2020. Ms. Novakovic has served as Chairman and Chief Executive Officer of General Dynamics Corporation since...(BusinessWire)

October 23, 2020
Diagnostic Testing Capabilities Improve in the Face of Global Turmoil

While biotech companies work on vaccines and possible treatments and medical device companies focus on patient monitoring solutions, many others have been working on improving testing options. For example, numerous companies are now racing to...(PR Newswire)

October 22, 2020
Global Smart Healthcare Market- Featuring Abbott Laboratories, Alphabet Inc., Allscripts Healthcare Solutions Inc., and Cisco Systems Inc. Among Others

The smart healthcare market is poised to grow by USD 224.86 billion during 2020-2024. This press release features multimedia. View the full release here: (BusinessWire)

October 21, 2020
Abbott Reports Third-Quarter 2020 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance

Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2020. -- Third-quarter worldwide sales of $8.9 billion increased 9.6 percent on a reported basis and 10.6 percent on an organic basis, which excludes the...(PR Newswire)

October 20, 2020
Teledyne Appoints Michelle Kumbier to Board of Directors

Teledyne Technologies Incorporated (NYSE:TDY) announced today the appointment of Michelle A. Kumbier, former Chief Operating Officer of Harley-Davidson Motor Company, to the company's Board of Directors, effective October 20, 2020. The addition of...(BusinessWire)

Recent Events Reinforce the Importance of Surface Sterilization

The pandemic continues to take a toll on the world's economy, and as a result, effective and cheap mass testing is needed to properly implement preventive measures. Since the pandemic has begun, three companies have gained authorization from the...(PR Newswire)

October 19, 2020
Improved Mental and Physical Condition is Directly Linked to Nutrition, Study Shows

Researchers at the University of Illinois, Urbana-Champaign, Abbott (NYSE: ABT), and the U.S. Air Force Research Lab announced today the results of a new study that found a direct link between physical fitness, cognitive performance, and optimal...(PR Newswire)

October 12, 2020
Vaccine Market Growth Predicted at 14.7% Through 2026: Global Market Insights, Inc.

According to the latest report "Vaccine Market by Age Group (Pediatric, Adult), Disease (Cancer, Hepatitis, Pneumococcal Disease, DTP, Dengue, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus), Technology (Conjugate, Live...(PR Newswire)

Abbott Receives FDA Emergency Use Authorization for its COVID-19 IgM Antibody Blood Test

Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company's AdviseDx SARS-CoV-2 IgM (Immunoglobulin M) lab-based serology test for use on the ARCHITECT(R) and...(PR Newswire)

October 09, 2020
Law Enforcement Software Market to Reach $ 437.24 mn by 2024, Abbott Laboratories, Accenture Plc, Oracle Corp., and Resolver Inc., Emerge as Key Contributors to Growth | Technavio

Technavio has been monitoring the law enforcement software market and it is poised to grow by USD 437.24 mn during 2020-2024, progressing at a CAGR of over 5% during the forecast period. The report offers an up-to-date analysis regarding the current...(BusinessWire)

October 08, 2020
Genetic Testing Market to reach $ 4.86 bn by 2024, Abbott Laboratories, Agilent Technologies Inc., and Thermo Fisher Scientific Inc., emerge as Key Contributors to growth | Technavio

Technavio has been monitoring the genetic testing market and it is poised to grow by $ 4.86 bn during 2020-2024, progressing at a CAGR of over 12% during the forecast period. The report offers an up-to-date analysis regarding the current market...(BusinessWire)

CLA Market to Reach USD 5.04 Billion By 2024, Abbott Laboratories and bioMerieux SA Emerge as Key Contributors to Growth| Technavio

Technavio has been monitoring the CLA market and it is poised to grow by USD 5.04 billion during 2020-2024, progressing at a CAGR of almost 9% during the forecast period. The report offers an up-to-date analysis regarding the current market...(BusinessWire)

Blood Glucose Monitoring Device Market to reach USD 15.60 billion by 2024, Abbott Laboratories and Agamatrix Inc. emerge as Key Contributors to growth | Technavio

Technavio has been monitoring the blood glucose monitoring device market and it is poised to grow by USD 15.60 billion during 2020-2024, progressing at a CAGR of almost 12% during the forecast period. The report offers an up-to-date analysis...(BusinessWire)

October 07, 2020
Abbott Releases ID NOW(TM) COVID-19 Interim Clinical Study Results from 1,003 People to Provide the Facts on Clinical Performance and to Support Public Health

In a continuing effort to provide the facts about ID NOW to support public health interests, Abbott (NYSE: ABT) is sharing new interim clinical data results on its ID NOW COVID-19 rapid test. The results confirm the data submitted to the U.S. Food...(PR Newswire)

October 05, 2020
Quanterix Enters into a License Agreement that Grants Abbott Access to Portfolio of Bead-Based Technology Patents for Use in In Vitro Diagnostics

Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into a non-exclusive royalty-bearing license agreement with Abbott Laboratories (NYSE: ABT), the...(BusinessWire)

October 02, 2020
In Vitro Diagnostics (IVD) Quality Control Market Was Worth US$ 900 Million in 2019, Globally

The Global In Vitro Diagnostics (IVD) Quality Control Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies, research & development activities, supply chain analysis, competitive...(Globe Newswire)

Roxanne S. Austin Elected to Verizon Board of Directors

Verizon Communications Inc. (NYSE, Nasdaq: VZ) today announced the election of Roxanne S. Austin to the Verizon Board of Directors, effective immediately. Ms. Austin is President and Chief Executive Officer of Austin Investment Advisors, a private...(Globe Newswire)

Thinking about trading options or stock in AstraZeneca, Assured Guaranty, Apple, Tesla, or Abbott Laboratories?

InvestorsObserver issues critical PriceWatch Alerts for AZN, AGO, AAPL, TSLA, and ABT. Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

Global Pneumonia Therapeutics Market Trajectory & Analytics Report 2020 Featuring Abbott Labs, Allergan, Bayer, GlaxoSmithKline, Lupin Pharma, Merck & Co, Novartis & Pfizer -

The "Pneumonia Therapeutics - Global Market Trajectory & Analytics" report has been added to's offering. Global Pneumonia Therapeutics Market to Reach US$22.5 Billion by the Year 2027 (BusinessWire)

October 01, 2020
Rising Incidence Of Viral Diseases And Increase In Elderly Population Are Causing Growth In The Anti-Viral Drug Therapy Market Size

(Anti-Viral Drug Therapy Companies Included: AbbVie Inc., Bristol-Myers-Squibb, Cipla, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Dr. Reddy's Laboratories Ltd, AstraZeneca plc...(Globe Newswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.